Concentrix (NASDAQ:CNXC – Get Free Report) and Phreesia (NYSE:PHR – Get Free Report) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.
Risk & Volatility
Concentrix has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Comparatively, Phreesia has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500.
Analyst Ratings
This is a summary of recent ratings and recommmendations for Concentrix and Phreesia, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Concentrix | 0 | 1 | 4 | 1 | 3.00 |
| Phreesia | 0 | 0 | 12 | 0 | 3.00 |
Earnings & Valuation
This table compares Concentrix and Phreesia”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Concentrix | $9.59 billion | 0.32 | $251.22 million | $3.99 | 11.86 |
| Phreesia | $419.81 million | 3.35 | -$136.88 million | ($1.02) | -23.45 |
Concentrix has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than Concentrix, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
90.3% of Concentrix shares are held by institutional investors. Comparatively, 92.1% of Phreesia shares are held by institutional investors. 3.2% of Concentrix shares are held by company insiders. Comparatively, 5.8% of Phreesia shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Profitability
This table compares Concentrix and Phreesia’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Concentrix | 2.61% | 16.67% | 5.63% |
| Phreesia | -20.43% | -32.78% | -22.37% |
Summary
Concentrix beats Phreesia on 9 of the 14 factors compared between the two stocks.
About Concentrix
Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications. It also offers customer lifecycle management; customer experience/user experience strategy and design; analytics and actionable insights; digital transformation services that design and engineer CX solutions to enable efficient customer self-service and build customer loyalty; customer engagement solutions and services that address the entirety of the customer lifecycle; AI technology that can intelligently act on customer intent to improve customer experience with non-human engagement; voice of the customer and analytics solutions to gather and analyze customer feedback to foster loyalty to, and growth with, clients; analytics and consulting solutions that synthesize data and provide professional insight to improve clients’ customer experience strategies; vertical business process outsourcing (BPO) services; and back office BPO services that support clients in non-customer facing areas. The company’s clients include technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, healthcare, and others, as well as global IPOs, social brands, and banks. Concentrix Corporation was founded in 2004 and is based in Newark, California.
About Phreesia
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.
